Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can magnetic pulses boost shock wave therapy for tennis elbow?

NCT ID NCT07802938

Symptom relief Sponsor: Ali Güneri Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 03, 2026 · Last updated Sep 04, 2026 · Updated 1 time

Summary

This trial tests whether adding pulsed electromagnetic field therapy (PEMF) to standard shock wave therapy eases pain and improves function in adults with tennis elbow, a condition causing pain on the outer side of the elbow. About 70 people with symptoms lasting at least 3 months will receive either shock wave therapy plus active PEMF or shock wave therapy plus a sham PEMF device, once a week for 5 weeks. Researchers will measure pain, grip strength, and tendon appearance on ultrasound before treatment, right after the 5 weeks, and again 3 months later.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Pulsed electromagnetic field therapy (PEMF) added to extracorporeal shock wave therapy (ESWT)
What this could lead to
If it works, adding PEMF to shock wave therapy could offer a drug-free way to reduce pain and improve grip strength in people with tennis elbow.
What could go wrong
This is a small, early-stage trial, and the sham control means some improvement may come from placebo. The added benefit of PEMF may turn out to be small or absent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18 and 65 years * Symptom duration of at least 3 months * Clinical diagnosis of unilateral lateral epicondylitis * Numeric Rating Scale (NRS) pain score of at least 4 * Ability and willingness to provide written informed consent Exclusion Criteria: * Injection treatment, including corticosteroid or platelet-rich plasma (PRP), within the previous 6 months * Previous application of physical therapy modalities to the affected region * Cervical radiculopathy, peripheral nerve entrapment neuropathy, or another neurological condition that may mimic lateral elbow pain * Uncontrolled diabetes mellitus, defined as HbA1c \>8%, or the presence of diabetic peripheral neuropathy * Rheumatoid arthritis or other inflammatory rheumatic diseases * Previous surgery involving the affected elbow * Elbow instability, significant limitation of joint range of motion, extensor tendon rupture, or a history of major trauma to the elbow * Other shoulder or upper extremity disorders that may explain lateral elbow pain * Active infection or open wound at the treatment site * Malignancy * Presence of a pacemaker, defibrillator, electronic implant, or other active implanted device * Pregnancy * Coagulopathy or anticoagulant use * Inability to complete the questionnaires because of cognitive impairment or expected poor adherence to follow-up

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lateral epicondylitis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

epicondylitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lateral epicondylitis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.